Information Journal Paper
APA:
Copy. (2020). Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. DIABETES AND METABOLIC SYNDROME, 14(4), 0-0. SID. https://sid.ir/paper/975609/en
Vancouver:
Copy. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. DIABETES AND METABOLIC SYNDROME[Internet]. 2020;14(4):0-0. Available from: https://sid.ir/paper/975609/en
IEEE:
Copy, “Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,” DIABETES AND METABOLIC SYNDROME, vol. 14, no. 4, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/975609/en